1.4.2024
New Jersey Law Journal (reprinted with permission)
For the December issue of the New Jersey Law Journal cannabis law column, Wilentz attorneys, Michael F. Schaff and Jennie M. Miller asked Christopher Riggs, chief counsel of the NJ-CRC, to respond to some questions that would (i) provide insight into the operations of the NJ-CRC, (ii) highlight the key developments in 2023, (iii) provide some helpful pointers to attorneys practicing in the cannabis field, and (iv) provide a preview of what is to come in 2024.
Attachment: A Q&A with NJ-CRC Chief Counsel On What's New for 2024
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.
Michael F. Schaff
Co-Chair, Corporate, Health and Cannabis Law Teams
Shareholder
732.855.6047
Jennie M. Miller
Associate
732.855.6179
